Dana-Farber Cancer Institute has named Michael Reney, MBA, its Chief Financial Officer (CFO), where he will be responsible for all financial operations, including accounts payable, financial planning and reporting, payroll, capital asset management, tax, and general and patient accounting.
“Financial management of health care has become increasingly complex,” said Edward J. Benz, Jr, MD, President and CEO of Dana-Farber. “Michael’s substantial financial experience, both in health-care delivery and in research, as well as his ability to identify business opportunities and develop long-term strategic plans, will make him a critical contributor to the leadership of the Institute.”
Mr. Reney has more than 25 years of experience working in leading Boston hospitals and health-care systems, most recently serving as Senior Vice President and CFO at Brigham and Women’s Health Care (BWHC). He has also served as Assistant Controller at Massachusetts General Hospital, Director of Corporate Accounting and Financial Reporting in the Partners Healthcare System, and Executive Director for Finance/Controller at BWHC.
“The opportunity to guide a world-class leader in cancer care through the new economic reality of health care is exciting to me. I’m passionate about Dana-Farber’s mission and vision,,” said Mr. Reney. ■
